Health and Fitness Health and Fitness
Mon, May 28, 2012
Sun, May 27, 2012
Sat, May 26, 2012
Fri, May 25, 2012
[ Fri, May 25th 2012 ] - Market Wire
GenVec Reports Inducement Award
[ Fri, May 25th 2012 ] - Market Wire
PTS (PTSH) Share Structure

Watson to Present at the Jefferies 2012 Global Healthcare Conference


Published on 2012-05-25 06:31:48 - Market Wire
  Print publication without navigation


Watson to Present at the Jefferies 2012 Global Healthcare Conference -- PARSIPPANY, N.J., May 25, 2012 /PRNewswire/ --

Watson to Present at the Jefferies 2012 Global Healthcare Conference

[ ]

PARSIPPANY, N.J., May 25, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: [ WPI ]), a leading specialty global pharmaceutical company, announced today that Siggi Olafsson, Watson's President of Global Generics, will provide an overview and update of the Company's business at the Jefferies 2012 Global Healthcare Conference on Monday, June 4, 2012 at 11:00AM Eastern Time at the Grand Hyatt in New York, New York.  The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Website at [ http://ir.watson.com ].  The webcast can also be accessed at the following URL:

[ http://wsw.com/webcast/jeff68/wpi/ ]

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. The Company is also developing biosimilar products in Women's Health and Oncology.  Additionally, Watson distributes generic and branded pharmaceuticals through its Anda, Inc. distribution business.  Watson has operations in many of the worlds established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at [ http://www.watson.com ].

CONTACTS:

Investors:


Lisa DeFrancesco


(862) 261-7152




Media:


Charlie Mayr


(862) 261-8030

(Logo: [ http://photos.prnewswire.com/prnh/20100121/LA41294LOGO ] )

 

SOURCE Watson Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.watson.com ]